In MYCN-amplified NB, overexpressed MYCN protein regulates its oncogenic targets; these include MDM2 and genes of the PI3k/Akt/mTOR and STAT signaling pathways, which have anti-apoptotic and growth-promoting effects for NB cells (3, 4). The gene discussed is SOAT1; the disease is neuroblastoma.